The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes

The Feasibility and Applicability of Stem Cell Therapy for the Cure of Type 1 Diabetes

Stem cell therapy using islet-like insulin-producing cells derived from human pluripotent stem cells has the potential to allow patients with type 1 diabetes to withdraw from insulin therapy. However, several issues exist regarding the use of stem cell therapy to treat type 1 diabetes. In this revie...

Full description

Bibliographic Details
Main Authors:	Ryota Inoue, Kuniyuki Nishiyama, Jinghe Li, Daisuke Miyashita, Masato Ono, Yasuo Terauchi, Jun Shirakawa
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Cells
Subjects:	diabetes type 1 diabetes stem cell therapy pancreatic β-cell
Online Access:	https://www.mdpi.com/2073-4409/10/7/1589

Similar Items

Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects
by: Mayu Kyohara, et al.
Published: (2020-09-01)

G protein‐coupled receptor 119 agonist DS‐8500a effects on pancreatic β‐cells in Japanese type 2 diabetes mellitus patients
by: Hirotaka Watada, et al.
Published: (2019-01-01)

Advances in Curing Type 1 Diabetes: Stem Cell Therapy, Bioprinting, and Islet Transplantation
by: Bijaya Ghosh, et al.
Published: (2023-10-01)

Generation of insulin-secreting cells from mouse gallbladder stem cells by small molecules in vitro
by: Fei Chen, et al.
Published: (2019-09-01)

Stem cell potential for type 1 diabetes therapy
by: Roche Enrique, et al.
Published: (2007-12-01)

Abdominal aortic calcification is associated with Fibrosis‐4 index and low body mass index in type 2 diabetes patients: A retrospective cross‐sectional study
by: Yu Togashi, et al.
Published: (2022-11-01)

β cell replacement therapy for the cure of diabetes
by: Joonyub Lee, et al.
Published: (2022-11-01)

Stepwise differentiation of functional pancreatic β cells from human pluripotent stem cells
by: Wenwen Jin, et al.
Published: (2022-08-01)

Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement
by: Xin-Xing Wan, et al.
Published: (2022-03-01)

Mesenchymal Stem Cells: A Trump Card for the Treatment of Diabetes?
by: Elisabetta Donzelli, et al.
Published: (2020-05-01)

Current progress in stem cell therapy for type 1 diabetes mellitus
by: Shuai Chen, et al.
Published: (2020-07-01)

Pancreatic Islet Transplantation in Patients suffering from Type 1 diabetes - Indications, methods, possible risks and future directions: A literature review
by: Marta Wolanin, et al.
Published: (2023-05-01)

Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
by: Mohamed M. Kamal, et al.
Published: (2020-01-01)

Stem Cells for Diabetes Complications: A Future Potential Cure
by: Mogher Khamaisi, et al.
Published: (2017-01-01)

β-Cell Replacement Strategies: The Increasing Need for a “β-Cell Dogma”
by: Andhira Vieira, et al.
Published: (2017-06-01)

The structural and functional recovery of pancreatic β-cells in type 1 diabetes mellitus induced mesenchymal stem cell-conditioned medium
by: Widagdo Sri Nugroho, et al.
Published: (2016-05-01)

Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant
by: Ali H. Shilleh, et al.
Published: (2023-02-01)

Adipose tissue-derived stromal/stem cells + cholecalciferol: a pilot study in recent-onset type 1 diabetes patients
by: Joana Rodrigues Dantas, et al.
Published: (2021-05-01)

Effective Generation of Functional Pancreatic β Cells from Human-Derived Dental Stem Cells of Apical Papilla and Bone-Marrow-Derived Stem Cells: A Comparative Study
by: Duaa Abuarqoub, et al.
Published: (2023-04-01)

The roles of mesenchymal stem cell-derived exosomes in diabetes mellitus and its related complications
by: Mengmeng Yang, et al.
Published: (2022-10-01)

Impact of Magnesium Deficiency on Pancreatic β-Cell Function in Type 2 Diabetic Nigerians
by: Mohammed Abdullahi, et al.
Published: (2019-06-01)

beta-cell transplantation in diabetes mellitus
by: S Pellegrini, et al.
Published: (2013-09-01)

Editorial: Mechanisms Underlying Diabetes-Associated Damage in Target Tissues
by: Beatriz Suarez-Alvarez, et al.
Published: (2022-05-01)

Stem cells and the pancreas: from discovery to clinical approach
by: Angelica Dessì, et al.
Published: (2016-02-01)

Beta-Cell Dysfunction Induced by Tacrolimus: A Way to Explain Type 2 Diabetes?
by: Ana Elena Rodriguez-Rodriguez, et al.
Published: (2021-09-01)

Modelling monogenic diabetes mutations using authentic human beta cell models
by: Duff, C
Published: (2020)

Piperine is capable of improving pancreatic β-cell apoptosis in high fat diet and streptozotocin induced diabetic mice
by: Qian He, et al.
Published: (2022-01-01)

Management of Type 1 diabetes mellitus with autologous mesenchymal stem cells
by: Pradeep V Mahajan, et al.
Published: (2019-01-01)

Human umbilical cord matrix-derived stem cells exert trophic effects on β-cell survival in diabetic rats and isolated islets
by: Yunting Zhou, et al.
Published: (2015-12-01)

Family history of diabetes in both parents is strongly associated with impaired residual β‐cell function in Japanese type 2 diabetes patients
by: Minoru Iwata, et al.
Published: (2020-05-01)

NKX6.1 transcription factor: a crucial regulator of pancreatic β cell development, identity, and proliferation
by: Idil I. Aigha, et al.
Published: (2020-10-01)

Contribution of pancreatic α‐cell function to insulin sensitivity and glycemic variability in patients with type 1 diabetes
by: Nobuyuki Takahashi, et al.
Published: (2019-05-01)

Differentiation of human bone marrow-derived mesenchymal stem cells into functional pancreatic beta cells
by: Ayla Eker Sariboyaci, et al.
Published: (2021-09-01)

Tissues derived from reprogrammed Wharton’s jelly stem cells of the umbilical cord as a platform to study gestational diabetes mellitus
by: Chiou Mee Kong, et al.
Published: (2020-08-01)

Selective ablation of P53 in pancreatic beta cells fails to ameliorate glucose metabolism in genetic, dietary and pharmacological models of diabetes mellitus
by: Celina Uhlemeyer, et al.
Published: (2023-01-01)

Physiological relevance of protein-glycosylation to pathogenesis of diabetes
by: Kazuaki Ohtsubo, et al.
Published: (2014-05-01)

Editorial: Revisiting cellular metabolism and type 1 diabetes
by: Vikash Chandra, et al.
Published: (2023-05-01)

Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes
by: Kevin Verhoeff, et al.
Published: (2021-01-01)

Validity and reliability of the Japanese version of the diabetes knowledge test among in‐patients with type 2 diabetes
by: Taichi Minami, et al.
Published: (2022-03-01)

Human Pluripotent Stem Cells Go Diabetic: A Glimpse on Monogenic Variants
by: Sandra Heller, et al.
Published: (2021-05-01)